Axcella Health Inc. (AXLA): Price and Financial Metrics
AXLA Price/Volume Stats
| Current price | $0.40 | 52-week high | $41.25 |
| Prev. close | $0.44 | 52-week low | $0.34 |
| Day low | $0.36 | Volume | 6,700 |
| Day high | $0.51 | Avg. volume | 267,009 |
| 50-day MA | $3.38 | Dividend yield | N/A |
| 200-day MA | $7.54 | Market Cap | 1.18M |
AXLA Stock Price Chart Interactive Chart >
Axcella Health Inc. (AXLA) Company Bio
Axcella Health Inc., a biotechnology company, researches and develops novel multifactorial interventions to support health and address dysregulated metabolism in the United States. The company develops its products based on its AXA Development Platform. It offers AXA1665 for use in treating hepatic encephalopathy; AXA1125 and AXA1957 to treat non-alcoholic fatty liver disease; AXA2678 for use in treating immobilization-induced acute muscle atrophy; and AXA4010 to target multiple biological pathways.
AXLA Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | -91.27% |
| 3-year | -99.46% |
| 5-year | -99.53% |
| YTD | -0.22% |
| 2023 | -95.10% |
| 2022 | -84.33% |
| 2021 | -59.73% |
| 2020 | 29.43% |
| 2019 | N/A |
Loading social stream, please wait...